- Investing Ideas
- /
- New Zealand Pharmaceuticals & Biotech Financially Fit Penny Stocks
New Zealand Pharmaceuticals & Biotech Financially Fit Penny Stocks
Results
2
0 new
A Penny Stocks screener, typically smaller or younger companies trading at a price below 5, with a focus on solid financial health that should present companies with a lower risk profile than other early-stage businesses
2 companies
BLIS Technologies
Market Cap: NZ$20.5m
Develops and sells healthcare products based on strains of bacteria that produce bacteriocin activity.
BLT
NZ$0.016
7D
-5.9%
1Y
-5.9%
Pacific Edge
Market Cap: NZ$66.6m
A cancer diagnostics company, engages in development and commercialization of bladder cancer diagnostic and prognostic tests for patients.
PEB
NZ$0.082
7D
0%
1Y
-19.6%